LegoChem Financial Statements From 2010 to 2024
| 141080 Stock | KRW 68,400 400.00 0.59% |
Check LegoChem Biosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among LegoChem main balance sheet or income statement drivers, such as , as well as many exotic indicators such as . LegoChem financial statements analysis is a perfect complement when working with LegoChem Biosciences Valuation or Volatility modules.
LegoChem |
LegoChem Biosciences Company Current Valuation Analysis
LegoChem Biosciences' Enterprise Value is a firm valuation proxy that approximates the current market value of a company. It is typically used to determine the takeover or merger price of a firm. Unlike Market Cap, this measure takes into account the entire liquid asset, outstanding debt, and exotic equity instruments that the company has on its balance sheet. When a takeover occurs, the parent company will have to assume the target company's liabilities but will take possession of all cash and cash equivalents.
Current LegoChem Biosciences Current Valuation | 1.09 T |
Most of LegoChem Biosciences' fundamental indicators, such as Current Valuation, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, LegoChem Biosciences is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Enterprise Value can be a useful tool to compare companies with different capital structures. Long term liability and current cash or cash equivalents can have a huge impact on market valuation of a given company.
| Competition |
In accordance with the recently published financial statements, LegoChem Biosciences has a Current Valuation of 1.09 T. This is much higher than that of the Life Sciences Tools & Services sector and significantly higher than that of the Health Care industry. The current valuation for all Republic of Korea stocks is notably lower than that of the firm.
LegoChem Biosciences Fundamental Drivers Relationships
Comparative valuation techniques use various fundamental indicators to help in determining LegoChem Biosciences's current stock value. Our valuation model uses many indicators to compare LegoChem Biosciences value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across LegoChem Biosciences competition to find correlations between indicators driving LegoChem Biosciences's intrinsic value. More Info.LegoChem Biosciences is number one stock in return on equity category among related companies. It is number one stock in return on asset category among related companies . Comparative valuation analysis is a catch-all model that can be used if you cannot value LegoChem Biosciences by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for LegoChem Biosciences' Stock. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued. The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the LegoChem Biosciences' earnings, one of the primary drivers of an investment's value.About LegoChem Biosciences Financial Statements
There are typically three primary documents that fall into the category of financial statements. These documents include LegoChem Biosciences income statement, its balance sheet, and the statement of cash flows. LegoChem Biosciences investors use historical funamental indicators, such as LegoChem Biosciences's revenue or net income, to determine how well the company is positioned to perform in the future. Although LegoChem Biosciences investors may use each financial statement separately, they are all related. The changes in LegoChem Biosciences's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on LegoChem Biosciences's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. We offer a historical overview of the basic patterns found on LegoChem Biosciences Financial Statements. Understanding these patterns can help to make the right decision on long term investment in LegoChem Biosciences. Please read more on our technical analysis and fundamental analysis pages.
LegoChem Biosciences, Inc. a biopharmaceutical company, focuses on the development of novel therapeutics utilizing its proprietary LegoChemistry medicinal drug discovery technology and ADC platform. LegoChem Biosciences, Inc. was founded in 2006 and is headquartered in Daejeon, South Korea. LegoChem Bio is traded on Korean Securities Dealers Automated Quotations in South Korea.
Thematic Opportunities
Explore Investment Opportunities
Check out the analysis of LegoChem Biosciences Correlation against competitors. Note that the LegoChem Biosciences information on this page should be used as a complementary analysis to other LegoChem Biosciences' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETF Categories module to list of ETF categories grouped based on various criteria, such as the investment strategy or type of investments.
Complementary Tools for LegoChem Stock analysis
When running LegoChem Biosciences' price analysis, check to measure LegoChem Biosciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy LegoChem Biosciences is operating at the current time. Most of LegoChem Biosciences' value examination focuses on studying past and present price action to predict the probability of LegoChem Biosciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move LegoChem Biosciences' price. Additionally, you may evaluate how the addition of LegoChem Biosciences to your portfolios can decrease your overall portfolio volatility.
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| CEOs Directory Screen CEOs from public companies around the world | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Risk-Return Analysis View associations between returns expected from investment and the risk you assume | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets | |
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| ETFs Find actively traded Exchange Traded Funds (ETF) from around the world | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency |